ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,192Medicare Part D Prescriptions Filled, Including Refills

Rank: 144 out of 6969

$804K Total Retail Price of All Prescriptions

Rank: 214 out of 6969

485 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 485 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

42% of this provider’s 485 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 12,114 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 1,153 819 S3 1 3
AMLODIPINE BESYLATE 638 517 2 4
OMEPRAZOLE 463 360 3 6
LISINOPRIL 446 387 4 2
LEVOTHYROXINE SODIUM 430 352 5 5
FUROSEMIDE 419 363 6 10
SIMVASTATIN 417 319 7 1
METFORMIN HCL 355 282 8 7
POTASSIUM CHLORIDE 336 291 9 30
METOPROLOL TARTRATE 323 288 10 13
PRAVASTATIN SODIUM 257 207 11 19
MELOXICAM 244 184 12 36
HYDROCHLOROTHIAZIDE 206 175 13 8
ATENOLOL 197 171 14 9
FLUTICASONE PROPIONATE 192 147 15 24
LOSARTAN POTASSIUM 192 153 15 12
ZOLPIDEM TARTRATE 185 130 17 16
SERTRALINE HCL 176 139 18 38
CARVEDILOL 172 154 19 25
LOVASTATIN 170 163 20 15
GLYBURIDE 166 159 R 21 54
ATORVASTATIN CALCIUM 162 132 22 11
GABAPENTIN 158 108 23 17
PANTOPRAZOLE SODIUM 157 120 24 31
TRIAMCINOLONE ACETONIDE 146 100 25 55
PROAIR HFA 144 94 26 33
WARFARIN SODIUM 143 135 27 20
IBUPROFEN 130 83 28 29
NAMENDA 101 100 29 51
BENAZEPRIL HCL 98 86 30 18
DIOVAN 97 94 31 26
CLONIDINE HCL 96 90 32 59
TAMSULOSIN HCL 93 83 33 23
ADVAIR DISKUS 92 82 34 45
GLIMEPIRIDE 91 75 35 44
AZITHROMYCIN 91 72 35 42
FLUOXETINE HCL 90 54 37 43
FAMOTIDINE 88 66 38 37
CLOPIDOGREL 88 76 38 48
TRAMADOL HCL 88 53 38 27
MEGESTROL ACETATE 88 88 R 38 129
HYDRALAZINE HCL 86 77 42 106
LANTUS 84 81 43 50
PLAVIX 81 72 44 68
LANTUS SOLOSTAR 78 50 45 154
DONEPEZIL HCL 77 77 46 32
NAPROXEN 75 54 47 62
PREDNISONE 73 67 48 70
BACLOFEN 71 40 49 86
PEN NEEDLE 71 57 49 196
DIVALPROEX SODIUM 69 29 51 103
CIPROFLOXACIN HCL 69 59 51 64
PAROXETINE HCL 69 53 51 65
ACTOS 68 54 54 61
ALENDRONATE SODIUM 66 51 55 14
METOPROLOL SUCCINATE 66 63 55 22
MECLIZINE HCL 65 60 57 100
LACTULOSE 64 58 58 131
ENALAPRIL MALEATE 64 45 58 56
JANUMET 63 62 60 138
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 40 60 28
DIGOXIN 60 56 62 71
VENTOLIN HFA 59 39 63 125
ALLOPURINOL 59 43 63 35
PHENYTOIN SODIUM EXTENDED 58 28 65 169
AMIODARONE HCL 57 57 66 184
METOCLOPRAMIDE HCL 56 50 67 136
TERAZOSIN HCL 55 55 68 49
FENTANYL 54 31 S2 69 113
ISOSORBIDE MONONITRATE ER 54 50 69 81
HUMALOG 53 49 71 167
HYDROXYZINE HCL 52 42 R 72 159
LOSARTAN-HYDROCHLOROTHIAZIDE 51 31 73 53
GEMFIBROZIL 50 29 74 85
RAMIPRIL 50 42 74 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.